ClinicalTrials.gg

Amgen clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 1,088 studies whose lead sponsor is Amgen or one of 9 companies grouped under it. 50 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 10 registry names, not the registry’s. See them and correct one ↓

Compare Amgen with Bristol-Myers Squibb and Hoffmann-La Roche →

Pipeline: 24 programs

Each counted once: 24 with a study Amgen leads registered in the last two years.

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4 (approved, new studies)

The 5 of 7 with the most live studies.

Program
maridebart cafraglutidePhase 3 · 19 live · Obesity · primary completion Nov 2026☆ Track
tarlatamabPhase 3 · 12 live · Small Cell Lung Carcinoma · primary completion Apr 2027☆ Track
xaluritamigPhase 3 · 7 live · Prostatic Neoplasms · primary completion Feb 2027☆ Track
sotorasibPhase 3 · 4 live · Carcinoma, Non-Small-Cell Lung · primary completion Dec 2026☆ Track
olpasiranPhase 3 · 3 live · Cardiovascular Diseases · primary completion Mar 2028☆ Track

2 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Amgen’s own registered studies; Amgen’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

Licenses and deals

One of Amgen’s programs has a dated deal behind it: 1 licensed out. Each from the companies’ own releases and filings, linked; the registry does not record them.

Licensed out 1

What it is testing

The drugs Amgen’s studies test, most open studies first — 143 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 143; every drug is on its own page, and each page lists its sponsors.

Coming up

36 of Amgen’s studies under way reach primary completion within a year, 14 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. 2D
  3. 6J’27
  4. 1F
  5. 3M
  6. 6A
  7. 2M
  8. 3J
  9. 3J
  10. 3A
  11. 1S
  12. 3O
  13. 1N

The 12 nearest

Show 7 more

Add all 36 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 1,088 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now505%Recruiting 45 · Not yet recruiting 5
  • Under way, not recruiting545%
  • Completed81575%
  • Stopped early14814%Terminated 128 · Withdrawn 17 · Suspended 3
  • Status unknown or other212%Status unknown 8 · No longer available 8 · Approved for marketing 4 · Available 1

Phase

Where

Over the years

  1. 07
  2. 08
  3. 09
  4. 10
  5. 11
  6. 5312
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 3226

By the year each study started; 238 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Amgen.

  • Amgen
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1,047 studies
  • Five Prime Therapeutics, Inc.
    Acquired — became part of Amgen, Apr 16, 2021 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    11 studies →
  • Amgen Research (Munich) GmbH
    Acquired — became part of Amgen, Mar 7, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    10 studies →
  • Tularik
    Acquired — became part of Amgen, Aug 13, 2004 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    7 studies →
  • BioVex Limited
    Acquired — became part of Amgen, Mar 4, 2011 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Abgenix
    Acquired — became part of Amgen, Apr 3, 2006 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →
  • Horizon Pharma Rheumatology LLC
    Acquired — became part of Amgen, Oct 6, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • deCODE genetics
    Acquired — became part of Amgen, Dec 10, 2012 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Viela Bio
    Acquired — became part of Amgen, Oct 6, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Horizon Therapeutics Ireland DAC
    Acquired — became part of Amgen, Oct 6, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Amgen leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Show all 47 areas

Studies

Recruiting first, then most recently updated. Showing 50 of 1,088. Browse all 1,088 →